Pharma Veterans

Manager Visibility is Not Enough for Leadership – Asrar Qureshi’s Blog Post #1315 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1315 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Gustavo Fring Preamble This post is based on Harvard Business School Professors Research. Link at the end. Walking the Floor Is Not Enough: Turning Management Visibility into Real Problem Solving Management books have long encouraged leaders to "walk the floor." The idea is simple and attractive: senior managers should leave their offices, visit the workplace, talk to employees, observe operations and discover problems firsthand. In pharmaceutical companies, this can mean a plant head walking through production, a sales director accompanying medical representatives, a commercial leader visiting distributors, a quality head ob...

New Thinking on Burnout – Asrar Qureshi’s Blog Post #1314 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1314 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Ron Lach Preamble This post is inspired by ideas from Scott H. Young article. Link at the end. Why Loving Your Work Can Sometimes Make You More Vulnerable To Burnout We usually think of burnout as something that happens to people who hate their jobs. The logic seems obvious. If work is exhausting, unrewarding and unpleasant, eventually a person will become emotionally and physically depleted. But what if the opposite can also be true? What if the people most passionate about their work can sometimes be especially vulnerable to burnout? That is the intriguing paradox explored by Scott Young in his recent essay The Paradox of Burnout. Young points out that ...

Conditional Approval and Pricing of New Drugs – Asrar Qureshi’s Blog Post #1313 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1313 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Pavel Danilyuk Preamble This post is based on INSEAD research by Professor Stephen E. Chick. This is a provocative research which answers and raises several questions.Link at the end. The Real Cost of Health Innovation: Who Pays for Life-Saving Breakthroughs? A new medicine can take more than a decade to reach a patient. It may require billions of dollars of investment, years of laboratory research, multiple stages of clinical trials and increasingly complex regulatory scrutiny. Even after demonstrating promising results, however, a new treatment can face another formidable barrier: will a health system actually pay for it and make i...

Cancer Treatment – Access is the Real Obstacle – Asrar Qureshi’s Blog Post #1312 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1312 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Ivan Samkov Preamble This post is based on a McKinsey article. The core McKinsey source is Bob Li's August 31, 2026 conversation, which outlines the MARS approach around next-generation evidence generation, community education, cancer networks, and international acceleration/collaboration. The wider cancer-burden figures and prevention/early-detection context come from WHO and IARC. Link at the end. Can We Eliminate Cancer? The Real Revolution May Be Access, Not Discovery Cancer has long been portrayed as an enemy that science must defeat through better drugs, better diagnostics and better technology. And there is good reason for th...

Effect of Tobacco on Fertility – Asrar Qureshi’s Blog Post #1311 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1311 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Alex Zvir Preamble This blogpost takes some insights from a recent World Health Organization report. Link to the report at the end. Tobacco and Fertility: The Hidden Reproductive Cost of Smoking For decades, the dangers of tobacco have been associated primarily with cancer, heart disease, stroke and chronic respiratory illness. Yet a new warning from the World Health Organization (WHO) highlights another consequence that receives far less public attention: tobacco use can undermine fertility. The finding is important because infertility is already a major global health concern. WHO estimates that approximately one in six people of reproductive age ...

Changing Demographic Trends and Development – Asrar Qureshi’s Blog Post #1310 Dear Colleagues! This is Asrar Qureshi’s Blog Post #1310 for Pharma Veterans. Pharma Veterans Blogs are published by Asrar Qureshi on its dedicated site https://pharmaveterans.com. Please email to pharmaveterans2017@gmail.com  for publishing your contributions here. Credit: Juan Philip Ramirez Credit: Rahul Varge Preamble This blogpost takes some insights from a recent article published in DevelopmentAid. Link to the article at the end. The Demographic Shift: What Changing Population Trends Mean for International Development For most of modern history, population growth was treated as one of the defining challenges of development. More people meant greater demand for food, housing, education, employment, healthcare and infrastructure. Governments and development agencies therefore focused heavily on managing rapid population growth and expanding services for growing populations. That picture is changing. ...